Correlation Between Abcellera Biologics and I Mab
Can any of the company-specific risk be diversified away by investing in both Abcellera Biologics and I Mab at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Abcellera Biologics and I Mab into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Abcellera Biologics and I Mab, you can compare the effects of market volatilities on Abcellera Biologics and I Mab and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Abcellera Biologics with a short position of I Mab. Check out your portfolio center. Please also check ongoing floating volatility patterns of Abcellera Biologics and I Mab.
Diversification Opportunities for Abcellera Biologics and I Mab
-0.41 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Abcellera and IMAB is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Abcellera Biologics and I Mab in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on I Mab and Abcellera Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Abcellera Biologics are associated (or correlated) with I Mab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of I Mab has no effect on the direction of Abcellera Biologics i.e., Abcellera Biologics and I Mab go up and down completely randomly.
Pair Corralation between Abcellera Biologics and I Mab
Given the investment horizon of 90 days Abcellera Biologics is expected to generate 0.72 times more return on investment than I Mab. However, Abcellera Biologics is 1.39 times less risky than I Mab. It trades about 0.06 of its potential returns per unit of risk. I Mab is currently generating about 0.03 per unit of risk. If you would invest 268.00 in Abcellera Biologics on September 14, 2024 and sell it today you would earn a total of 27.00 from holding Abcellera Biologics or generate 10.07% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Abcellera Biologics vs. I Mab
Performance |
Timeline |
Abcellera Biologics |
I Mab |
Abcellera Biologics and I Mab Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Abcellera Biologics and I Mab
The main advantage of trading using opposite Abcellera Biologics and I Mab positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Abcellera Biologics position performs unexpectedly, I Mab can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in I Mab will offset losses from the drop in I Mab's long position.Abcellera Biologics vs. Hepion Pharmaceuticals | Abcellera Biologics vs. Krystal Biotech | Abcellera Biologics vs. CureVac NV | Abcellera Biologics vs. Vir Biotechnology |
I Mab vs. Puma Biotechnology | I Mab vs. Iovance Biotherapeutics | I Mab vs. Day One Biopharmaceuticals | I Mab vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |